Search

Your search keyword '"Oberlin, Odile"' showing total 500 results
Start Over Author "Oberlin, Odile"
500 results on '"Oberlin, Odile"'

1. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

Author

Dirksen, Uta, Brennan, Bernadette, Le Deley, Marie-Cécile, Cozic, Nathalie, van den Berg, Henk, Bhadri, Vivek, Brichard, Bénédicte, Claude, Line, Craft, Alan, Amler, Susanne, Gaspar, Natalie, Gelderblom, Hans, Goldsby, Robert, Gorlick, Richard, Grier, Holcombe E, Guinbretiere, Jean-Marc, Hauser, Peter, Hjorth, Lars, Janeway, Katherine, Juergens, Heribert, Judson, Ian, Krailo, Mark, Kruseova, Jarmila, Kuehne, Thomas, Ladenstein, Ruth, Lervat, Cyril, Lessnick, Stephen L, Lewis, Ian, Linassier, Claude, Marec-Berard, Perrine, Marina, Neyssa, Morland, Bruce, Pacquement, Hélène, Paulussen, Michael, Randall, R Lor, Ranft, Andreas, Le Teuff, Gwénaël, Wheatley, Keith, Whelan, Jeremy, Womer, Richard, Oberlin, Odile, Hawkins, Douglas S, and Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators

Subjects
Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators, Humans, Bone Neoplasms, Lung Neoplasms, Neoplasm Recurrence, Local, Disease Progression, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy, Radiotherapy, Adjuvant, Pneumonectomy, Hematopoietic Stem Cell Transplantation, Transplantation, Autologous, Risk Assessment, Risk Factors, Time Factors, Adolescent, Adult, Middle Aged, Child, Child, Preschool, Infant, Europe, Female, Male, Young Adult, Sarcoma, Ewing, Progression-Free Survival, Lung, Stem Cell Research, Cancer, Pediatric, Rare Diseases, Clinical Research, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Clinical Sciences, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

PurposeThe R2Pulm trial was conducted to evaluate the effect of busulfan-melphalan high-dose chemotherapy with autologous stem-cell rescue (BuMel) without whole-lung irradiation (WLI) on event-free survival (main end point) and overall survival, compared with standard chemotherapy with WLI in Ewing sarcoma (ES) presenting with pulmonary and/or pleural metastases.MethodsFrom 2000 to 2015, we enrolled patients younger than 50 years of age with newly diagnosed ES and with only pulmonary or pleural metastases. Patients received chemotherapy with six courses of vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) and one course of vincristine, dactinomycin, and ifosfamide (VAI) before either BuMel or seven courses of VAI and WLI (VAI plus WLI) by randomized assignment. The analysis was conducted as intention to treat. The estimates of the hazard ratio (HR), 95% CI, and P value were corrected for the three previous interim analyses by the inverse normal method.ResultsOf 543 potentially eligible patients, 287 were randomly assigned to VAI plus WLI (n = 143) or BuMel (n = 144). Selected patients requiring radiotherapy to an axial primary site were excluded from randomization to avoid excess organ toxicity from interaction between radiotherapy and busulfan. Median follow-up was 8.1 years. We did not observe any significant difference in survival outcomes between treatment groups. Event-free survival was 50.6% versus 56.6% at 3 years and 43.1% versus 52.9% at 8 years, for VAI plus WLI and BuMel patients, respectively, resulting in an HR of 0.79 (95% CI, 0.56 to 1.10; P = .16). For overall survival, the HR was 1.00 (95% CI, 0.70 to 1.44; P = .99). Four patients died as a result of BuMel-related toxicity, and none died after VAI plus WLI. Significantly more patients in the BuMel arm experienced severe acute toxicities than in the VAI plus WLI arm.ConclusionIn ES with pulmonary or pleural metastases, there is no clear benefit from BuMel compared with conventional VAI plus WLI.

Published
2019

2. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

Author

Cesen, Maja, Rose, Adriana, Ferman, Sima, Mudry, Peter, Sejnova, Daniela, Dal Bianco, Paola, Zanetti, Ilaria, Niggli, Felix, Rogers, Timothy, Cecchetto, Giovanni, De Corti, Federica, Guerin, Florent, Terwisscha, Sheila, Ranchere, Dominique, Alaggio, Rita, Shipley, Janet, Rosolen, Angelo, Mandeville, Henry, Scarzello, Giovanni, Bernier, Valerie, McHugh, Kieran, Bisogno, Gianni, Jenney, Meriel, Bergeron, Christophe, Gallego Melcón, Soledad, Ferrari, Andrea, Oberlin, Odile, Carli, Modesto, Stevens, Michael, Kelsey, Anna, De Paoli, Angela, Gaze, Mark N, Martelli, Helene, Devalck, Christine, Merks, Johannes H, Ben-Arush, Myriam, Glosli, Heidi, Chisholm, Julia, Orbach, Daniel, Minard-Colin, Veronique, and De Salvo, Gian Luca

Published
2018
Full Text
View/download PDF

3. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)

Author

Chisholm, Julia C., Merks, Johannes H.M., Casanova, Michela, Bisogno, Gianni, Orbach, Daniel, Gentet, Jean-Claude, Thomassin-Defachelles, Anne-Sophie, Chastagner, Pascal, Lowis, Stephen, Ronghe, Milind, McHugh, Kieran, van Rijn, Rick R., Hilton, Magalie, Bachir, Jeanette, Fürst-Recktenwald, Sabine, Geoerger, Birgit, and Oberlin, Odile

Published
2017
Full Text
View/download PDF

5. Supplementary Table 1 from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 4 from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table 2 from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

8. Data from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table and Figure Legends from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 3 from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 5 from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figures 1 - 5 from Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Author

Tirode, Franck, primary, Surdez, Didier, primary, Ma, Xiaotu, primary, Parker, Matthew, primary, Le Deley, Marie Cécile, primary, Bahrami, Armita, primary, Zhang, Zhaojie, primary, Lapouble, Eve, primary, Grossetête-Lalami, Sandrine, primary, Rusch, Michael, primary, Reynaud, Stéphanie, primary, Rio-Frio, Thomas, primary, Hedlund, Erin, primary, Wu, Gang, primary, Chen, Xiang, primary, Pierron, Gaelle, primary, Oberlin, Odile, primary, Zaidi, Sakina, primary, Lemmon, Gordon, primary, Gupta, Pankaj, primary, Vadodaria, Bhavin, primary, Easton, John, primary, Gut, Marta, primary, Ding, Li, primary, Mardis, Elaine R., primary, Wilson, Richard K., primary, Shurtleff, Sheila, primary, Laurence, Valérie, primary, Michon, Jean, primary, Marec-Bérard, Perrine, primary, Gut, Ivo, primary, Downing, James, primary, Dyer, Michael, primary, Zhang, Jinghui, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

13. Data from Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

Author

Bourdeaut, Franck, primary, Lequin, Delphine, primary, Brugières, Laurence, primary, Reynaud, Stéphanie, primary, Dufour, Christelle, primary, Doz, François, primary, André, Nicolas, primary, Stephan, Jean-Louis, primary, Pérel, Yves, primary, Oberlin, Odile, primary, Orbach, Daniel, primary, Bergeron, Christophe, primary, Rialland, Xavier, primary, Fréneaux, Paul, primary, Ranchere, Dominique, primary, Figarella-Branger, Dominique, primary, Audry, Georges, primary, Puget, Stéphanie, primary, Evans, D. Gareth, primary, Pinas, Joan Carles Ferreres, primary, Capra, Valeria, primary, Mosseri, Véronique, primary, Coupier, Isabelle, primary, Gauthier-Villars, Marion, primary, Pierron, Gaëlle, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Data from Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

Author

Bourdeaut, Franck, primary, Lequin, Delphine, primary, Brugières, Laurence, primary, Reynaud, Stéphanie, primary, Dufour, Christelle, primary, Doz, François, primary, André, Nicolas, primary, Stephan, Jean-Louis, primary, Pérel, Yves, primary, Oberlin, Odile, primary, Orbach, Daniel, primary, Bergeron, Christophe, primary, Rialland, Xavier, primary, Fréneaux, Paul, primary, Ranchere, Dominique, primary, Figarella-Branger, Dominique, primary, Audry, Georges, primary, Puget, Stéphanie, primary, Evans, D. Gareth, primary, Pinas, Joan Carles Ferreres, primary, Capra, Valeria, primary, Mosseri, Véronique, primary, Coupier, Isabelle, primary, Gauthier-Villars, Marion, primary, Pierron, Gaëlle, primary, and Delattre, Olivier, primary

Published
2023
Full Text
View/download PDF

17. Paratesticular rhabdomyosarcoma in children and adolescents—Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies

Author

Rogers, Timothy, Minard‐Colin, Veronique, Cozic, Nathalie, Jenney, Meriel, Merks, Johannes H. M., Gallego, Soledad, Devalck, Christine, Gaze, Mark N., Kelsey, Anna, Oberlin, Odile, Stevens, Mike, Spicer, Richard D., Bergeron, Christophe, and Martelli, Helene

Published
2017
Full Text
View/download PDF

18. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study

Author

Vaarwerk, Bas, van der Lee, Johanna H., Breunis, Willemijn B., Orbach, Daniel, Chisholm, Julia C., Cozic, Nathalie, Jenney, Meriel, van Rijn, Rick R., McHugh, Kieran, Gallego, Soledad, Glosli, Heidi, Devalck, Christine, Gaze, Mark N., Kelsey, Anna, Bergeron, Christophe, Stevens, Michael C. G., Oberlin, Odile, Minard‐Colin, Veronique, and Merks, Johannes H. M.

Published
2018
Full Text
View/download PDF

19. Hodgkin Lymphoma

Author

Trippett, Tanya M., Mottl, Alexis, Oberlin, Odile, Bleyer, Archie, Constine, Louis S., Bleyer, W. Archie, editor, and Barr, Ronald D., editor

Published
2007
Full Text
View/download PDF

20. Predictive factors of long‐term follow‐up attendance in very long‐term childhood cancer survivors.

Author

Dumas, Agnes, Milcent, Karen, Bougas, Nicolas, Bejarano‐Quisoboni, Daniel, El Fayech, Chiraz, Charreire, Hélène, Oberlin, Odile, Patte, Catherine, Allard, Julie, Thebault, Eric, Boumaraf, Amel, Belhout, Amel, Giao, Vu‐Bezin, Souchard, Vincent, Jackson, Angela, Allodji, Rodrigue, Valteau‐Couanet, Dominique, Dufour, Christelle, Vassal, Gilles, and Haddy, Nadia

Subjects
CHILDHOOD cancer, CANCER survivors, CENTRAL nervous system tumors, STEM cell transplantation, SOCIAL marginality, LOGISTIC regression analysis
Abstract

Background: Long‐term follow‐up (LTFU) clinics have been developed but only some childhood cancer survivors (CCS) attend long‐term follow‐up (LTFU). Objective: To identify factors that influence LTFU attendance. Methods: Five‐year CCS treated for a solid tumor or lymphoma in Gustave Roussy before 2000, included in the FCCSS cohort (French Childhood Cancer Survivor Study), aged >18 years and alive at the date of the LTFU Clinic opening (January 2012) were invited to a LTFU visit. Factors associated with attendance at the LTFU clinic between 2012 and 2020 were estimated using logistic regression analyses. Analyses included different types of factors: clinical (tumor characteristics, cancer treatments, late effects), medical (medical expenses were used as a proxy of survivor's health status), social (deprivation index based on census‐tract data relating to income, educational level, proportion of blue‐collar workers, and unemployed people living in the area of residence), and spatial (distance to the LTFU clinic). Results: Among 2341 CCS contacted (55% males, mean age at study, 45 years; SD ± 10 years; mean age at diagnosis, 6 years; SD ± 5 years), 779 (33%) attended at least one LTFU visit. Initial cancer‐related factors associated with LTFU visit attendance were: treatment with both radiotherapy and chemotherapy (odds ratio [OR], 4.02; 95% CI, 2.11–7.70), bone sarcoma (OR, 2.43; 95% CI, 1.56–3.78), central nervous system primitive tumor (OR, 1.65; 95% CI, 1.02–2.67), and autologous hematopoietic cell transplant (OR, 2.07; 95% CI, 1.34‐3.20). Late effects (OR, 1.70; 95% CI, 1.31–2.20), highest medical expenses (OR, 1.65; 95% CI, 1.22–2.22), living in the most advantaged area (OR vs. the most deprived area = 1.60; 95% CI, 1.15–2.22), and shorter distance from LTFU care center (<12 miles) also increased attendance. Conclusions: Patients who are apparently healthy as well as socially disadvantaged and living far away from the center are less likely to attend LTFU care. Plain Language Summary: Among 2341 adult childhood cancer survivors contacted between 2012 and 2020, 33% attended at least one long‐term follow‐up visit.Clinical factors related to attendance were multimodal treatment of first cancer (combining chemotherapy and radiotherapy), stem cell transplant, type of diagnosis (bone tumor and central nervous system primitive tumor), late effects (at least one disease among second malignancy, heart disease, or stroke), and highest medical expenses.In addition, the study identified social and spatial inequalities related to attendance, with independent negative effects of distance and social deprivation on attendance, even though the medical costs related to the long‐term follow‐up examinations are covered by the French social security system. Among 2341 adult childhood cancer survivors contacted between 2012 and 2020, 33% attended at least one long‐term follow‐up visit. Clinical factors related to attendance were multimodal treatment of first cancer (combining chemotherapy and radiotherapy), stem cell transplant, type of diagnosis (bone tumor and central nervous system primitive tumor), late effects (at least one disease among second malignancy, heart disease, or stroke ascertained from a physician or a medical record) and highest medical expenses (used as a proxy of survivor's health status in adulthood). In addition, the study identified social and spatial inequalities related to attendance, with independent negative effects of distance and social deprivation on attendance, even though the medical costs related to the long‐term follow‐up examinations are covered by the French social security system. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. Educational and occupational outcomes of childhood cancer survivors 30 years after diagnosis: a French cohort study

Author

Dumas, Agnes, Berger, Claire, Auquier, Pascal, Michel, Gérard, Fresneau, Brice, Allodji, Rodrigue Sètchéou, Haddy, Nadia, Rubino, Carole, Vassal, Gilles, Valteau-Couanet, Dominique, Thouvenin-Doulet, Sandrine, Casagranda, Léonie, Pacquement, Hélène, El-Fayech, Chiraz, Oberlin, Odile, Guibout, Catherine, and de Vathaire, Florent

Published
2016
Full Text
View/download PDF

24. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite

Author

Grünewald, Thomas G P, Bernard, Virginie, Gilardi-Hebenstreit, Pascale, Raynal, Virginie, Surdez, Didier, Aynaud, Marie-Ming, Mirabeau, Olivier, Cidre-Aranaz, Florencia, Tirode, Franck, Zaidi, Sakina, Perot, Gaëlle, Jonker, Anneliene H, Lucchesi, Carlo, Le Deley, Marie-Cécile, Oberlin, Odile, Marec-Bérard, Perrine, Véron, Amélie S, Reynaud, Stephanie, Lapouble, Eve, Boeva, Valentina, Frio, Thomas Rio, Alonso, Javier, Bhatia, Smita, Pierron, Gaëlle, Cancel-Tassin, Geraldine, Cussenot, Olivier, Cox, David G, Morton, Lindsay M, Machiela, Mitchell J, Chanock, Stephen J, Charnay, Patrick, and Delattre, Olivier

Published
2015
Full Text
View/download PDF

26. Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma – A report from the Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE)

Author

Minard-Colin, Véronique, Ichante, Jean-Laurent, Nguyen, Laurent, Paci, Angelo, Orbach, Daniel, Bergeron, Christophe, Defachelles, Anne-Sophie, André, Nicolas, Corradini, Nadège, Schmitt, Claudine, Tabone, Marie-Dominique, Blouin, Pascale, Sirvent, Nicolas, Goma, Gisele, Geoerger, Birgit, and Oberlin, Odile

Published
2012
Full Text
View/download PDF

32. Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groups

Author

Ferrari, Andrea, Miceli, Rosalba, Rey, Annie, Oberlin, Odile, Orbach, Daniel, Brennan, Bernadette, Mariani, Luigi, Carli, Modesto, Bisogno, Gianni, Cecchetto, Giovanni, Salvo, Gian Luca De, Casanova, Michela, Vannoesel, Max M., Kelsey, Anna, Stevens, Michael C., Devidas, Meenakshi, Pappo, Alberto S., and Spunt, Sheri L.

Published
2011
Full Text
View/download PDF

33. Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment

Author

Schwartz, Boris, Benadjaoud, Mohamed Amine, Cléro, Enora, Haddy, Nadia, El-Fayech, Chiraz, Guibout, Catherine, Teinturier, Cécile, Oberlin, Odile, Veres, Cristina, Pacquement, Hélène, Munzer, Martine, N’Guyen, Tan Dat, Bondiau, Pierre-Yves, Berchery, Delphine, Laprie, Anne, Hawkins, Mike, Winter, David, Lefkopoulos, Dimitri, Chavaudra, Jean, Rubino, Carole, Diallo, Ibrahima, Bénichou, Jacques, and de Vathaire, Florent

Published
2014
Full Text
View/download PDF

35. The development of an international childhood cancer hospital register database in 13 African countries. A project of the French African Pediatric Oncology Group (GFAOP)

Author

Mallon, Brenda, primary, Kaboré, Rolande, additional, Couitchere, Line, additional, Akonde, Fatou Binetou, additional, Lukamba, Robert, additional, Dackono, Tankélé Arsène, additional, Narison, Mbolanirina Lala Rakotomahefa, additional, Khattab, Mohammed, additional, Pondy, Angèle, additional, Fedhila Ben Ayed, Faten, additional, Budiongo, Aléine, additional, Guedenon, Koffi, additional, Oberlin, Odile, additional, and Patte, Catherine, additional

Published
2021
Full Text
View/download PDF

37. Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer

Author

de Vathaire, Florent, Haddy, Nadia, Allodji, Rodrigue S., Hawkins, Mike, Guibout, Catherine, El-Fayech, Chiraz, Teinturier, Cécile, Oberlin, Odile, Pacquement, Hélène, Diop, Fara, Kalhouche, Amar, Benadjaoud, Mohamedamine, Winter, David, Jackson, Angela, Bezin Mai-Quynh, Giao, Benabdennebi, Aymen, Llanas, Damien, Veres, Cristina, Munzer, Martine, Nguyen, Tan Dat, Bondiau, Pierre-Yves, Berchery, Delphine, Laprie, Anne, Deutsch, Eric, Lefkopoulos, Dimitri, Schlumberger, Martin, Diallo, Ibrahima, and Rubino, Carole

Published
2015

46. Smoking and Cannabis Use among Childhood Cancer Survivors: Results of the French Childhood Cancer Survivor Study

Author

Bougas, Nicolas, primary, Fresneau, Brice, additional, Pinto, Sandrine, additional, Mayet, Aurélie, additional, Marchi, Joffrey, additional, Pein, François, additional, Mansouri, Imene, additional, Journy, Neige M.Y., additional, Jackson, Angela, additional, Souchard, Vincent, additional, Demoor-Goldschmidt, Charlotte, additional, Vu-Bezin, Giao, additional, Rubino, Carole, additional, Oberlin, Odile, additional, Haddy, Nadia, additional, de Vathaire, Florent, additional, Allodji, Rodrigue S., additional, and Dumas, Agnès, additional

Published
2021
Full Text
View/download PDF

48. Impact of extensive surgery in multidisciplinary approach of pterygopalatine/infratemporal fossa soft tissue sarcoma

Author

Minard-Colin, Véronique, Kolb, Frédéric, Saint-Rose, Christian, Fayard, Florence, Janot, François, Rey, Annie, Canale, Sandra, Julieron, Morbize, Corradini, Nadège, Raquin, Marie-Anne, Habrand, Jean-Louis, Grill, Jacques, George, Bernard, Ba Huy, Patrice Tran, Couloignier, Vincent, Terrier-Lacombe, Marie-José, Luboinski, Bernard, Valteau-Couanet, Dominique, and Oberlin, Odile

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results